Medicare AdvantageBilling CodesLow impact
MA11.049h, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
Independence Blue Cross·Audiology, ENT (Ear, Nose & Throat)·Medical Policy
Effective date
May 27, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued MA11.049h effective 05/27/2026 with a code update adding five new CPT codes (0951T-0955T) to the Experimental/Investigational section for bone-anchored and implantable middle ear hearing aids. This is a minor administrative reissuance clarifying the Company's continuing coverage position; no changes to covered/non-covered services occurred.
Action Required
By May 27, 2026: Billing team must update billing software and claim denial logic to recognize CPT codes 0951T, 0952T, 0953T, 0954T, and 0955T as Experimental/Investigational for bone-anchored and implantable middle ear hearing aids under Independence Blue Cross Medicare Advantage plans. Any claims submitted with these codes should be denied as experimental/investigational unless the member has specific coverage under their plan's investigational benefit. No immediate action required; this is a future-dated reissuance. Verify current coverage criteria remain unchanged (CPT 69714, 69716, 69717 and HCPCS L8618, L8624, L8625, L8690 remain medically necessary when medical necessity criteria are met).